NCT04499755View on ClinicalTrials.gov

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 1, 2030

Study Completion Date

December 10, 2030

Conditions
Brain Injuries
Interventions
DRUG

Nucleo CMP Forte

Nucleo CMP Forte twice daily for 6 weeks

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Sherief Abd-Elsalam

OTHER

NCT04499755 - Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics | Biotech Hunter | Biotech Hunter